Cargando…

Anaphylaxis caused by tipepidine hibenzate, a central antitussive drug

Tipepidine hibenzate, a central antitussive drug, is widely used in the management of cough and is generally safe and well tolerated. We present here a case of anaphylaxis caused by this drug. When the patient had caught a cold over the previous 10 years, she had received medications, including tipe...

Descripción completa

Detalles Bibliográficos
Autores principales: Mochizuki, Eisuke, Shirai, Toshihiro, Noguchi, Rie, Mitsui, Chihiro, Taniguchi, Masami, Suda, Takafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364787/
https://www.ncbi.nlm.nih.gov/pubmed/25802739
http://dx.doi.org/10.1002/rcr2.85
_version_ 1782362129372807168
author Mochizuki, Eisuke
Shirai, Toshihiro
Noguchi, Rie
Mitsui, Chihiro
Taniguchi, Masami
Suda, Takafumi
author_facet Mochizuki, Eisuke
Shirai, Toshihiro
Noguchi, Rie
Mitsui, Chihiro
Taniguchi, Masami
Suda, Takafumi
author_sort Mochizuki, Eisuke
collection PubMed
description Tipepidine hibenzate, a central antitussive drug, is widely used in the management of cough and is generally safe and well tolerated. We present here a case of anaphylaxis caused by this drug. When the patient had caught a cold over the previous 10 years, she had received medications, including tipepidine hibenzate, from her family doctor. However, this time, she developed dyspnea, skin eruption, and anaphylactic shock after taking a Chinese herbal medicine and this drug. After her conditions improved due to adequate treatment, she was referred to our hospital to confirm the causative drug. Double-blind placebo-controlled oral challenge tests were performed after obtaining informed consent. Oral challenge with one-third tablet dose of tipepidine hibenzate caused a positive reaction. Urinary leukotriene E4 rose during the challenge with tipepidine hibenzate, but not with control. Clinicians should keep in mind that common antitussive drug use can cause anaphylactic reactions in very rare cases and can be harmful.
format Online
Article
Text
id pubmed-4364787
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BlackWell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-43647872015-03-23 Anaphylaxis caused by tipepidine hibenzate, a central antitussive drug Mochizuki, Eisuke Shirai, Toshihiro Noguchi, Rie Mitsui, Chihiro Taniguchi, Masami Suda, Takafumi Respirol Case Rep Case Reports Tipepidine hibenzate, a central antitussive drug, is widely used in the management of cough and is generally safe and well tolerated. We present here a case of anaphylaxis caused by this drug. When the patient had caught a cold over the previous 10 years, she had received medications, including tipepidine hibenzate, from her family doctor. However, this time, she developed dyspnea, skin eruption, and anaphylactic shock after taking a Chinese herbal medicine and this drug. After her conditions improved due to adequate treatment, she was referred to our hospital to confirm the causative drug. Double-blind placebo-controlled oral challenge tests were performed after obtaining informed consent. Oral challenge with one-third tablet dose of tipepidine hibenzate caused a positive reaction. Urinary leukotriene E4 rose during the challenge with tipepidine hibenzate, but not with control. Clinicians should keep in mind that common antitussive drug use can cause anaphylactic reactions in very rare cases and can be harmful. BlackWell Publishing Ltd 2015-03 2014-12-02 /pmc/articles/PMC4364787/ /pubmed/25802739 http://dx.doi.org/10.1002/rcr2.85 Text en © 2014 The Authors. Respirology Case Reports published by John Wiley & Sons Ltd on behalf of The Asian Pacific Society of Respirology. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Case Reports
Mochizuki, Eisuke
Shirai, Toshihiro
Noguchi, Rie
Mitsui, Chihiro
Taniguchi, Masami
Suda, Takafumi
Anaphylaxis caused by tipepidine hibenzate, a central antitussive drug
title Anaphylaxis caused by tipepidine hibenzate, a central antitussive drug
title_full Anaphylaxis caused by tipepidine hibenzate, a central antitussive drug
title_fullStr Anaphylaxis caused by tipepidine hibenzate, a central antitussive drug
title_full_unstemmed Anaphylaxis caused by tipepidine hibenzate, a central antitussive drug
title_short Anaphylaxis caused by tipepidine hibenzate, a central antitussive drug
title_sort anaphylaxis caused by tipepidine hibenzate, a central antitussive drug
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364787/
https://www.ncbi.nlm.nih.gov/pubmed/25802739
http://dx.doi.org/10.1002/rcr2.85
work_keys_str_mv AT mochizukieisuke anaphylaxiscausedbytipepidinehibenzateacentralantitussivedrug
AT shiraitoshihiro anaphylaxiscausedbytipepidinehibenzateacentralantitussivedrug
AT noguchirie anaphylaxiscausedbytipepidinehibenzateacentralantitussivedrug
AT mitsuichihiro anaphylaxiscausedbytipepidinehibenzateacentralantitussivedrug
AT taniguchimasami anaphylaxiscausedbytipepidinehibenzateacentralantitussivedrug
AT sudatakafumi anaphylaxiscausedbytipepidinehibenzateacentralantitussivedrug